267 related articles for article (PubMed ID: 22285229)
1. Effect of non-steroidal anti-inflammatory drugs and new fenamate analogues on TRPC4 and TRPC5 channels.
Jiang H; Zeng B; Chen GL; Bot D; Eastmond S; Elsenussi SE; Atkin SL; Boa AN; Xu SZ
Biochem Pharmacol; 2012 Apr; 83(7):923-31. PubMed ID: 22285229
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological comparison of novel synthetic fenamate analogues with econazole and 2-APB on the inhibition of TRPM2 channels.
Chen GL; Zeng B; Eastmond S; Elsenussi SE; Boa AN; Xu SZ
Br J Pharmacol; 2012 Nov; 167(6):1232-43. PubMed ID: 22646516
[TBL] [Abstract][Full Text] [Related]
3. Activation of TRPC cationic channels by mercurial compounds confers the cytotoxicity of mercury exposure.
Xu SZ; Zeng B; Daskoulidou N; Chen GL; Atkin SL; Lukhele B
Toxicol Sci; 2012 Jan; 125(1):56-68. PubMed ID: 21984481
[TBL] [Abstract][Full Text] [Related]
4. Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs.
Hu H; Tian J; Zhu Y; Wang C; Xiao R; Herz JM; Wood JD; Zhu MX
Pflugers Arch; 2010 Mar; 459(4):579-92. PubMed ID: 19888597
[TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory agent flufenamic acid depresses store-operated channels by altering mitochondrial calcium homeostasis.
Tu P; Brandolin G; Bouron A
Neuropharmacology; 2009; 56(6-7):1010-6. PubMed ID: 19233217
[TBL] [Abstract][Full Text] [Related]
6. Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels.
Zhu Y; Lu Y; Qu C; Miller M; Tian J; Thakur DP; Zhu J; Deng Z; Hu X; Wu M; McManus OB; Li M; Hong X; Zhu MX; Luo HR
Br J Pharmacol; 2015 Jul; 172(14):3495-509. PubMed ID: 25816897
[TBL] [Abstract][Full Text] [Related]
7. Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3.
Klose C; Straub I; Riehle M; Ranta F; Krautwurst D; Ullrich S; Meyerhof W; Harteneck C
Br J Pharmacol; 2011 Apr; 162(8):1757-69. PubMed ID: 21198543
[TBL] [Abstract][Full Text] [Related]
8. The first ankyrin-like repeat is the minimum indispensable key structure for functional assembly of homo- and heteromeric TRPC4/TRPC5 channels.
Schindl R; Frischauf I; Kahr H; Fritsch R; Krenn M; Derndl A; Vales E; Muik M; Derler I; Groschner K; Romanin C
Cell Calcium; 2008 Mar; 43(3):260-9. PubMed ID: 17624425
[TBL] [Abstract][Full Text] [Related]
9. TRPC5 activation kinetics are modulated by the scaffolding protein ezrin/radixin/moesin-binding phosphoprotein-50 (EBP50).
Obukhov AG; Nowycky MC
J Cell Physiol; 2004 Nov; 201(2):227-35. PubMed ID: 15334657
[TBL] [Abstract][Full Text] [Related]
10. A gain-of-function SNP in TRPC4 cation channel protects against myocardial infarction.
Jung C; Gené GG; Tomás M; Plata C; Selent J; Pastor M; Fandos C; Senti M; Lucas G; Elosua R; Valverde MA
Cardiovasc Res; 2011 Aug; 91(3):465-71. PubMed ID: 21427121
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the calcium-activated chloride current in cardiac ventricular myocytes by N-(p-amylcinnamoyl)anthranilic acid (ACA).
Gwanyanya A; Macianskiene R; Bito V; Sipido KR; Vereecke J; Mubagwa K
Biochem Biophys Res Commun; 2010 Nov; 402(3):531-6. PubMed ID: 20971070
[TBL] [Abstract][Full Text] [Related]
12. Potent, selective, and subunit-dependent activation of TRPC5 channels by a xanthine derivative.
Minard A; Bauer CC; Chuntharpursat-Bon E; Pickles IB; Wright DJ; Ludlow MJ; Burnham MP; Warriner SL; Beech DJ; Muraki K; Bon RS
Br J Pharmacol; 2019 Oct; 176(20):3924-3938. PubMed ID: 31277085
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TRPC5 channels by intracellular ATP.
Dattilo M; Penington NJ; Williams K
Mol Pharmacol; 2008 Jan; 73(1):42-9. PubMed ID: 17925457
[TBL] [Abstract][Full Text] [Related]
14. Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice.
Just S; Chenard BL; Ceci A; Strassmaier T; Chong JA; Blair NT; Gallaschun RJ; Del Camino D; Cantin S; D'Amours M; Eickmeier C; Fanger CM; Hecker C; Hessler DP; Hengerer B; Kroker KS; Malekiani S; Mihalek R; McLaughlin J; Rast G; Witek J; Sauer A; Pryce CR; Moran MM
PLoS One; 2018; 13(1):e0191225. PubMed ID: 29385160
[TBL] [Abstract][Full Text] [Related]
15. Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain.
Fowler MA; Sidiropoulou K; Ozkan ED; Phillips CW; Cooper DC
PLoS One; 2007 Jun; 2(6):e573. PubMed ID: 17593972
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of fenamates as Slo2.1 channel activators.
Garg P; Sanguinetti MC
Mol Pharmacol; 2012 Nov; 82(5):795-802. PubMed ID: 22851714
[TBL] [Abstract][Full Text] [Related]
17. Gs cascade regulates canonical transient receptor potential 5 (TRPC5) through cAMP mediated intracellular Ca2+ release and ion channel trafficking.
Hong C; Kim J; Jeon JP; Wie J; Kwak M; Ha K; Kim H; Myeong J; Kim SY; Jeon JH; So I
Biochem Biophys Res Commun; 2012 Apr; 421(1):105-11. PubMed ID: 22490661
[TBL] [Abstract][Full Text] [Related]
18. Clemizole hydrochloride is a novel and potent inhibitor of transient receptor potential channel TRPC5.
Richter JM; Schaefer M; Hill K
Mol Pharmacol; 2014 Nov; 86(5):514-21. PubMed ID: 25140002
[TBL] [Abstract][Full Text] [Related]
19. Stretch-induced TRPC4 downregulation is accompanied by reduced capacitative Ca2+ entry in WKY but not SHR mesenteric smooth muscle cells.
Lindsey SH; Songu-Mize E
Clin Exp Hypertens; 2010; 32(5):288-92. PubMed ID: 20662729
[TBL] [Abstract][Full Text] [Related]
20. Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABA
Mansikkamäki S; Sinkkonen ST; Korpi ER; Lüddens H
Eur J Pharmacol; 2019 Jun; 853():247-255. PubMed ID: 30930251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
